Hepatitis, Drug-Induced

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hepatitis, Drug-Induced trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 4 trials

RecruitingNot Applicable

NCT06864481

Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis

Background and Study Rationale Immune checkpoint inhibitors (ICI) are a breakthrough cancer treatment that boosts the immune system to fight tumors. While effec…

France250 participantsStarted 2025-04-22

Treatment: Blood samples

RecruitingPhase 4

NCT06484530

Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis

Tuberculosis (TB) remains a significant public health concern in Thailand and globally, especially in tropical regions, with pulmonary TB being predominant. Bes…

Thailand116 participantsStarted 2024-03-12

Treatment: N acetyl cysteine

RecruitingNot Applicable

NCT06180590

The Efficacy of Vosevi in Treating DAA-experienced Patients

Hepatitis C virus (HCV) infection remains a significant health problem in our country. The World Health Organization estimated that 71 million people worldwide…

China200 participantsStarted 2023-02-28

Treatment: Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi]

RecruitingNot Applicable

NCT05361603

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures

The principle is to propose dedicated monthly screening days bringing together the health personnel involved (hepatologist, addictologist, nurse in charge of th…

France1,500 participantsStarted 2017-05-24

All recent trials (82 shown)

Active — Not RecruitingNot Applicable

NCT05657106

Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk

This study will test the effectiveness, implementation outcomes, and cost effectiveness of a community-tailored, harm reduction kiosk in reducing HIV, hepatitis…

United States752 participantsStarted 2023-03-06

Treatment: Harm reduction kiosk

Not Yet RecruitingNot Applicable

NCT06766331

Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans

Opioid use disorder (OUD) confers a higher risk of acquiring and transmitting infectious diseases, which may have long-term health consequences in Veterans. Tre…

United States60 participantsStarted 2028-04-03

Treatment: Integrated care

Hepatitis, Drug-Induced

Trial phase breakdown

Trial status

Actively recruiting — 4 trials

Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis

Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis

The Efficacy of Vosevi in Treating DAA-experienced Patients

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures

All recent trials (82 shown)

Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk

Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans

Trial phase breakdown

Trial status

Actively recruiting — 4 trials

Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis

Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis

The Efficacy of Vosevi in Treating DAA-experienced Patients

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures

All recent trials (82 shown)

Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk

Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans

miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 Trial

Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inje…

Digoxin In Treatment of Alcohol Associated Hepatitis

Integrated Treatment of Hepatitis C Virus Infection

Community Intervention to Eliminate HCV Among People Who Use Drugs.

The Kentucky Viral Hepatitis Treatment Study

The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes

The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City

Buprenorphine Integration Research and Community Health

HepC Micro-elimination on MSM and TGW Population.

Ending Transmission of HIV, HCV, and STDs and Overdose in Rural Communities of People Who Inject Drugs (ETHIC)

Community-Based, Client-Centered Prevention Homes to Address the Rural Opioid Epidemic- Aim 3

Eliminating HCV in Rural South Carolina Utilizing NP Led Mobile Clinics and Virtual Care Coordination

Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE)

Rural New England Health Study (Phase 2)

Effects of T-bet B Cells in Persistent Virus Control After Discontinuance of NAs in CHB Patients

Discrimination of DILI and AIH by Artificial Intelligence

HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels